Ilya Pharma recieves decision to grant from European Patent Office for its second patent covering the ILP-drug candidates and their use in skin and mucosa in humans and animals
News
Ilya Pharma participates in Global Scale Up program Powered by Health~Holland, Top Sector Life Sciences & Health
The Scale-up Investor Ready Program prepares entrepreneurs for the transatlantic investor market and increases the chances of successful financing.
Open position: CFO
Ilya Pharma will present Poster with AMR data for ILP100 at US military medical partnering conference MHSRS August 26-29 August, Kissimmee, FL
Ilya Pharma will present new data in antimicrobial resistance (AMR) and the bacterial killing activity of ILP100 on multi-drug-resitant (MDR) pathogenic bacteria isolated from War victims in Ukraine.